High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis.
Yeh S, Wroblewski K, Buggage R, Li Z, Kurup SK, Sen HN, Dahr S, Sran P, Reed GF, Robinson R, Ragheb JA, Waldmann TA, Nussenblatt RB.
J Autoimmun. 2008 Sep;31(2):91-7. Epub 2008 Jun 20.PMID: 18571896 [PubMed - indexed for MEDLINE]Related articlesFree article